» Articles » PMID: 37231058

Inducible TgfbR1 and Pten Deletion in a Model of Tongue Carcinogenesis and Chemoprevention

Overview
Date 2023 May 25
PMID 37231058
Authors
Affiliations
Soon will be listed here.
Abstract

Head and neck squamous cell carcinoma (HNSCC) is a significant public health problem, with a need for novel approaches to chemoprevention and treatment. Preclinical models that recapitulate molecular alterations that occur in clinical HNSCC patients are needed to better understand molecular and immune mechanisms of HNSCC carcinogenesis, chemoprevention, and efficacy of treatment. We optimized a mouse model of tongue carcinogenesis with discrete quantifiable tumors via conditional deletion of Tgfβr1 and Pten by intralingual injection of tamoxifen. We characterized the localized immune tumor microenvironment, metastasis, systemic immune responses, associated with tongue tumor development. We further determined the efficacy of tongue cancer chemoprevention using dietary administration of black raspberries (BRB). Three Intralingual injections of 500 µg tamoxifen to transgenic K14 Cre, floxed Tgfbr1, Pten (2cKO) knockout mice resulted in tongue tumors with histological and molecular profiles, and lymph node metastasis similar to clinical HNSCC tumors. Bcl2, Bcl-xl, Egfr, Ki-67, and Mmp9, were significantly upregulated in tongue tumors compared to surrounding epithelial tissue. CD4+ and CD8 + T cells in tumor-draining lymph nodes and tumors displayed increased surface CTLA-4 expression, suggestive of impaired T-cell activation and enhanced regulatory T-cell activity. BRB administration resulted in reduced tumor growth, enhanced T-cell infiltration to the tongue tumor microenvironment and robust antitumoral CD8+ cytotoxic T-cell activity characterized by greater granzyme B and perforin expression. Our results demonstrate that intralingual injection of tamoxifen in Tgfβr1/Pten 2cKO mice results in discrete quantifiable tumors suitable for chemoprevention and therapy of experimental HNSCC.

Citing Articles

Current State of Research on Health-Promoting Functional Properties in Berry-Based Foods.

Corfield R, Gomez Mattson M, Perez O, Salvatori D, Schebor C Curr Nutr Rep. 2025; 14(1):22.

PMID: 39862275 DOI: 10.1007/s13668-025-00615-6.


Berries vs. Disease: Revenge of the Phytochemicals.

Lamenza F, Upadhaya P, Roth P, Shrestha S, Jagadeesha S, Horn N Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256917 PMC: 10818490. DOI: 10.3390/ph17010084.


Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses.

Upadhaya P, Lamenza F, Shrestha S, Roth P, Jagadeesha S, Pracha H Antioxidants (Basel). 2023; 12(9).

PMID: 37759970 PMC: 10525528. DOI: 10.3390/antiox12091667.

References
1.
Dinesman A, Haughey B, Gates G, Aufdemorte T, Von Hoff D . Development of a new in vivo model for head and neck cancer. Otolaryngol Head Neck Surg. 1990; 103(5 ( Pt 1)):766-74. DOI: 10.1177/019459989010300517. View

2.
Ryan N, Anderson K, Volpedo G, Hamza O, Varikuti S, Satoskar A . STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma. Int J Cancer. 2019; 146(6):1717-1729. PMC: 7366342. DOI: 10.1002/ijc.32781. View

3.
van Horssen R, Ten Hagen T, Eggermont A . TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist. 2006; 11(4):397-408. DOI: 10.1634/theoncologist.11-4-397. View

4.
Knobloch T, Uhrig L, Pearl D, Casto B, Warner B, Clinton S . Suppression of Proinflammatory and Prosurvival Biomarkers in Oral Cancer Patients Consuming a Black Raspberry Phytochemical-Rich Troche. Cancer Prev Res (Phila). 2015; 9(2):159-71. PMC: 4764140. DOI: 10.1158/1940-6207.CAPR-15-0187. View

5.
Fruman D, Chiu H, Hopkins B, Bagrodia S, Cantley L, Abraham R . The PI3K Pathway in Human Disease. Cell. 2017; 170(4):605-635. PMC: 5726441. DOI: 10.1016/j.cell.2017.07.029. View